News

How family and science moved Exelixis’ new CMO to work on oncology blockbusters; While John Maraganore racks up the prizes, his old crew at Alnylam selects president

Vicki Goodman After 18 years at the FDA and climbing the corporate ladder in biopharma, Vicki Goodman is now in the biotech C-suite for the first time. The new CMO and executive VP of product […]

No Picture
News

ALSP Orchid Acquisition Corporation I Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing January 10, 2022

SEATTLE–(BUSINESS WIRE)–ALSP Orchid Acquisition Corporation I (Nasdaq: ALORU) (the “Company” or “ALSP Orchid”) announced today that, commencing January 10, 2022, holders of the units sold in the Company’s initial public offering of 172,500,000 units, completed […]

No Picture
News

STERIFRE MEDICAL GRANTED EPA REGISTRATION FOR AUTOMATED, POINT OF CARE DISINFECTANT SYSTEM TO HELP COMBAT COVID-19 AND OTHER HEALTHCARE ASSOCIATED PATHOGENS

KIRKLAND, Wash.: KIRKLAND, Wash., Jan. 6, 2022 /PRNewswire/ — In a significant move to fight COVID-19 and other contagious pathogens in health care settings, the U.S. Environmental Protection Agency (EPA) has granted Sterifre Medical, Inc. […]

No Picture
News

Zymeworks to Present at 40th Annual J.P. Morgan Healthcare Conference

VANCOUVER, British Columbia & SEATTLE–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that Neil Klompas, Zymeworks’ Chief Operating Officer and Chief Financial Officer, will present at the upcoming 40th […]

No Picture
News

RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagents

SEATTLE: SEATTLE, Jan. 6, 2022 /PRNewswire/ — RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services recognized over 100% sales growth in their Services business in 2021. They also […]

No Picture
News

Seattle Children’s collaboration to dive into cell therapy manufacturing; After success in court, Teva found guilty in NY

A cell and gene therapy company is extending its collaboration with Seattle Children’s Hospital to establish manufacturing practices for cell therapy, the company announced Tuesday. BioLife’s new lentiviral vector manufacturing site, dubbed VectorWorks, will be […]